A

Arthurian Life Sciences

50 employees

Arthurian Life Sciences Ltd is an investment manager specialising in the life sciences sector.

Investor insights

Sectors invested in

Health Care6
Medical4
Therapeutics3
Biotechnology3
Medical Device3
Hospital1
Hardware1
Pharmaceutical1
EdTech1
Health Diagnostics1
Education1
Internet1
Insulin Patch1
Pumps1
Type 2 diabetes1
Insulin delivery1
glucose management1
Drug Delivery1
Type 1 diabetes1
CF1

Funding rounds participated in

$19M sweet spot round size

Most of their 8 investments are in rounds between $7.8M and $39M

Investor type

Venture Capital

Basic info

Industry

investment management

Sectors

Deal leadership
Financial Services
Portfolio Management
Life Science Specialists
Co-Investment
Finance
Investment Capital
Venture Capital

Date founded

2012

Investments made

V

Verona Pharma raised $65M on June 20, 2016

Investors: Aisling Capital, OrbiMed Advisors, Andera Partners, Vivo Capital, Novo Holdings, Abingworth and Arthurian Life Sciences

R

Rutherford Health plc raised undisclosed on January 1, 2016

Investors: Arthurian Life Sciences

A

Apitope raised $13M on September 29, 2015

Investors: Wyvernfund.com, Vesalius Biocapital, PMV Pharmaceuticals, Inc. and Arthurian Life Sciences

C

CeQur raised $100M on September 1, 2015

Investors: Woodford Investment Management, VI Partners AG, Endeavour Vision and Arthurian Life Sciences

S

Sphere Medical raised $19M on April 21, 2015

Investors: Parkwalk Advisors and Arthurian Life Sciences

U

Undisclosed raised $7.5M on December 1, 2014

Investors: Arthurian Life Sciences

-

- raised $7.8M on August 19, 2014

Investors: Arthurian Life Sciences

R

ReNeuron raised $39M on July 22, 2013

Investors: Arthurian Life Sciences

FAQ